LCTC Lifeloc Technologies, Inc Insider Trading

CFO KORNELSEN bought 12,250 shares of LCTC at $3.80 on 2025-02-28; stock now -44.4% from 52-week high.

CFO Vern D. Kornelsen purchased 12,250 shares at $3.80 on 2025-02-28, adding 0.6% to his holdings of 2.10M shares. The stock has declined -44.4% from its 52-week high of $5.58 and is trading -15.5% below its 30-day average, suggesting a purchase during a period of significant weakness. While Kornelsen's cross-ticker track record shows 100% win rate on 90-day returns (averaging +14.5%), his prior trade at LCTC on 2024-07-23 also posted +14.5% at 90 days, indicating timing discipline. However, the company's fundamentals are concerning: revenue of $2.1M in the latest quarter has contracted -8.5% year-over-year, and the firm remains unprofitable with net income of -$158.3K over its most recent full fiscal year. The purchase occurs against both depressed stock price action and deteriorating operating results.

Director Siecke buys 9,347 shares of LCTC at $1.57; stock now $3.10, down 44.4% from 52-week high.

Director Donald E. Siecke purchased 9,347 shares at $1.57, increasing his holdings by 2.1% to 460,295 shares. The company faces material headwinds: it reported a quarterly revenue of $2.1M with a net loss of $158.3K, and annual revenue declined 8.5% year-over-year with full-year net income negative. The stock trades at $3.10, down 44.4% from its 52-week high of $5.58 and off 15.5% over the past 30 days. While Siecke's cross-ticker track record shows a 100% win rate with positive 90-day returns, his prior LCTC purchase on 2024-07-23 achieved +11.8% 30-day and +14.5% 90-day returns, suggesting he may have identified value in past. However, the current deteriorating fundamentals and significant recent price weakness present the critical context for evaluating this purchase.

10% Owner EDCO PARTNERS LLLP bought 34,800 shares of LCLC at $3.80 on 2025-02-28; 2 other insiders bought within 14 days.

EDCO PARTNERS LLLP, a 10% shareholder, purchased 34,800 shares at $3.80 on 2025-02-28, increasing holdings from 2,065,319 to 2,100,119 shares. This represents a +1.7% increase in the insider's position. The transaction occurred as part of a cluster pattern: 2 other insiders also bought within the same 14-day window, suggesting coordinated or independently motivated confidence among multiple company stakeholders. The company reported quarterly revenue of $2,087,326.00 with a net loss of $-158,327.00, though annual revenue growth stands at +10.0%, indicating underlying operational growth despite near-term profitability challenges. The insider's prior buy at this ticker on 2024-07-23 is not yet measurable at the 90-day mark, and cross-ticker history shows only 1 prior buy overall, limiting the ability to assess this insider's track record for timing accuracy.

Director Kashenberg buys 1,000 shares at $3.80; 2 other insiders bought within 14 days amid -38.7% drawdown from 52-week high

Kashenberg Adam W., a director of Lifeloc Technologies (LCTC), purchased 1,000 shares at $3.80 on 2025-02-28, establishing a first recorded position of 1,000 shares. This purchase occurs as part of a cluster pattern, with 2 other insiders also buying within the past 14 days. The stock currently trades at $3.42, down 38.7% from its 52-week high of $5.58, suggesting the accumulation occurs following a material decline. The company shows mixed fundamentals: while annual revenue growth stands at +10.0%, the latest quarter produced a net loss of $-158,327.00 on revenue of $2,087,326.00 ($2.1M), and the stock trades at a P/E of 42.75 despite negative earnings. The coordinated buying activity by multiple insiders at depressed valuations warrants investor attention to track whether this reflects confidence in a recovery path or whether subsequent filings and earnings will clarify the directors' underlying assessment.

LCTC CFO buys 45,620 shares at $3.80; 3 other insiders bought in past 14 days

CFO Vern D. Kornelsen purchased 45,620 shares at $3.80 on 2024-07-23, increasing his holdings from 1,960,668 to 2,006,288 shares (+2.3%). This transaction occurs within a broader cluster pattern: 3 other insiders have also bought LCTC shares within the same 14-day window. The company shows mixed fundamentals—latest quarterly revenue is $2,153,443.00 with a net loss of $283,806.00, though annual revenue growth stands at +10.0%. The stock trades at $3.80, representing -11.6% from its 52-week high of $4.30. The convergence of multiple insider purchases at reduced valuations alongside positive annual revenue growth suggests potential alignment among the insider group, though the unprofitable quarterly result and modest market cap of $9,325,640.80 warrant scrutiny of underlying business trajectory.

Director Kornelsen buys 2,132 shares of LCTC at $3.80; 3 other insiders bought within 14 days

Kornelsen Michael, a Director, purchased 2,132 shares at $3.80 on 2024-07-23, increasing his holdings from 25,368 to 27,500 shares (+8.4%). The transaction occurred within a cluster pattern: 3 other insiders also bought within the past 14 days. Lifeloc trades at $3.80, down -11.6% from its 52-week high of $4.30, creating a favorable entry point relative to recent peaks. The company faces profitability headwinds with net income at $-283,806.00 against quarterly revenue of $2,153,443.00, though annual revenue growth stands at +10.0%. The convergence of multiple insider purchases during a period of depressed valuation (relative to 52-week highs) and negative earnings warrants scrutiny of whether internal stakeholders perceive value or are responding to near-term operational concerns.

Director Siecke bought 78,057 shares of LCTC at $3.80 on 2024-07-23; cluster pattern with 3 other insiders buying in past 14 days.

Siecke Donald E., a director, purchased 78,057 shares at $3.80, increasing his holdings from 460,295 shares to 538,352 shares (a +17.0% increase in his position). This transaction is part of a coordinated cluster pattern: 3 other insiders also bought within the past 14 days, suggesting aligned views at the board/management level. The stock trades at $3.80, which is -11.6% below its 52-week high of $4.30, placing this purchase in a relatively depressed price window within the year's range. However, the underlying business shows modest momentum—revenue growth is +10.0% year-over-year and the stock is +2.7% over 90 days—though profitability remains negative (latest quarter net income: $-283,806.00). The convergence of multiple insider purchases at a discount to recent highs, combined with positive revenue trajectory, warrants investor attention to the board's conviction and any catalysts that might justify their accumulation.

EDCO PARTNERS LLLP (Director) buys 210,000 shares of LCLC at $3.80; joins cluster of 3 other insiders buying within 14 days

Director-level insider EDCO PARTNERS LLLP purchased 210,000 shares at $3.80, increasing holdings by 11.3% to 2.07M shares. This transaction is part of a coordinated cluster pattern, with 3 other insiders also purchasing within the past 14 days, suggesting potential alignment among company leadership on current share valuations. Lifeloc is generating $2.2M quarterly revenue with positive annual growth of 10.0%, though the company is currently unprofitable with a net loss of $-283.8K in the latest quarter. The clustering of director-level buying activity warrants monitoring, though investor context—including price trend relative to this $3.80 transaction price and the pathway to profitability—is necessary for full assessment.